About Me

As a medical oncologist and Chief of Memorial Sloan Kettering’s Lymphoma Service, I work with my clinical and basic-science colleagues to accelerate the translation of recent scientific discoveries into novel treatment strategies to improve the cure rate and survival of patients with Hodgkin and non-Hodgkin lymphoma.

Read more

I joined Memorial Sloan Kettering in 2013 with two decades of experience in treating and managing people with lymphoma, and with an extensive background in translational scientific research. I am particularly interested in developing novel targeted therapies and linking them to biomarkers (early markers) that can help match patients with the most effective and minimally  toxic medicines.

I have served as the principal investigator of more than 60 clinical trials in patients with Hodgkin and non-Hodgkin lymphoma, including national and international multi-center studies. I have led the efforts of developing the first FDA-approved targeted drug for the treatment of Hodgkin lymphoma in more than three decades (Brentuximab vedotin).

Nationally, I have led a National Cancer Institute-funded Specialized Programs of Research Excellence (SPOREs) in lymphoma focused on developing novel treatment strategies for Hodgkin and non-Hodgkin lymphoma. I also serve on the Scientific Advisory Board of the Lymphoma Research Foundation, and am a member of the National Cancer Institute Lymphoma Steering Committee.

I actively post on social media about clinical trials, news stories, scientific publications, and medical advances. You can follow me on Twitter and like my page on Facebook to stay connected.

  • Clinical Expertise: Hodgkin and Non-Hodgkin Lymphomas; New Targeted Therapies
  • Languages Spoken: English
  • Education: MD, University of Damascus School of Medicine
  • Residencies: Pathology - Medical College of Ohio; Internal Medicine - SUNY Downstate Medical Center
  • Fellowships: Hematology/Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

My Research

View my lab

See Anas Younes’ laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of Anas Younes’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.

Read more

Clinical Trials Led by Anas Younes

Clinical Trials Co-Investigated by Anas Younes


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more